Michelle C Manvell

Repeated nebulisation of non-viral CFTR gene therapy in patients with cystic fibrosis: a randomised, double-blind, placebo-controlled, phase 2b trial

Eric W.F.W. Alton, David K Armstrong, Deborah Ashby et al. · The Lancet Respiratory Medicine · 2015 · 417 citations · Full text

Characterisation of LMD virus-like nanoparticles self-assembled from cationic liposomes, adenovirus core peptide μ (mu) and plasmid DNA

Takanobu Tagawa, Michelle C Manvell, Neal Brown et al. · Gene Therapy · 2002 · 78 citations

Dna Nanotechnology, Protein Nanoparticles, Cationic Liposomes +5

A randomised, double-blind, placebo-controlled trial of repeated nebulisation of non-viral cystic fibrosis transmembrane conductance regulator (CFTR) gene therapy in patients with cystic fibrosis

Eric W.F.W. Alton, David K Armstrong, Deborah Ashby et al. · Efficacy and Mechanism Evaluation · 2016 · 45 citations · Full text

Secondary Clinical Outcomes, Inflammatory Lung Disease, In Vivo Gene Therapy +16

Limitations of the Murine Nose in the Development of Nonviral Airway Gene Transfer

Uta Griesenbach, Stephanie Jones, Emma Holder et al. · American Journal of Respiratory Cell and Molecular Biology · 2009 · 19 citations

An immunocytochemical assay to detect human CFTR expression following gene transfer

Heather Davidson, Abigail Wilson, Robert D. Gray et al. · Molecular and Cellular Probes · 2009 · 13 citations

Signal Transduction, Molecular Physiology, Protein Expression +9